Sealable beverage bottle

Details for Australian Patent Application No. 2002346930 (hide)

Owner Matheis, K.

Inventors Matheis, Karl

Agent Griffith Hack

Pub. Number AU-B-2002346930

PCT Number PCT/EP02/11583

PCT Pub. Number WO2003/053810

Priority 102 02 902.4 25.01.02 DE; 201 19 969.6 10.12.01 DE; 102 12 877.4 22.03.02 DE

Filing date 16 October 2002

Wipo publication date 9 July 2003

Acceptance publication date 5 January 2006

International Classifications

B65D 81/24 (2006.01) Containers, packaging elements, or packages, of special types or forms or specially adapted for organisms, articles, or materials presenting particular transport, storage, or dispensing problems - Adaptations for preventing deterioration or decay of contents

B65D 23/00 (2006.01) Details of rigid or semi-rigid containers not otherwise provided for

B65D 45/02 (2006.01) Clamping or other pressure-applying devices for securing or retaining closure members

B67B 7/02 (2006.01) Hand- or power-operated devices for opening closed containers

C12G 1/00 (2006.01) Preparation of wine or sparkling wine

Event Publications

13 March 2003 Complete Application Filed

  Priority application(s): 102 02 902.4 25.01.02 DE; 201 19 969.6 10.12.01 DE; 102 12 877.4 22.03.02 DE

2 October 2003 Application Open to Public Inspection

  Published as AU-B-2002346930

5 January 2006 Application Accepted

  Published as AU-B-2002346930

11 May 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002346931-VESSEL WITH FRAMEWORK-TYPE SUPPORTING TRUSS-FRAME

2002346929-5-ACYLAMINO-1,1-BIPHENYL-4-CAR BOXAMIDE DERIVATIVES AND THEIR USE AS P38 KINASE INHIBITORS